Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4872749

CN(C1CCC(NCc2ccc3c(c2)CCO3)CC1)S(=O)(=O)c1ccc(Nc2nccc(Nc3ccc(F)cc3)n2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.40
TRPV1 Q8NER1 1/20 0.37
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
MAPT P10636 3/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 1/20 0.34
ALOX12 P18054 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
TRPA1 O75762 1/20 0.34
POLB P06746 1/20 0.34
EPHB4 P54760 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
IGF1R P08069 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14020227 0.95 PLK1 (0.42) PLK1TRPV1HSP90AA1HSP90AB1MAPT
Trifluoroacetic Acid SCHEMBL4880005 0.86 IGF1R (0.36) MAPTAPOBEC3AAPOBEC3GL3MBTL1RAB9A
Trifluoroacetic Acid SCHEMBL4883699 0.86 MEN1 (0.36) MAPTAPOBEC3AAPOBEC3GL3MBTL1RAB9A
Trifluoroacetic Acid SCHEMBL4873354 0.86 EPHB4 (0.41) MAPTAPOBEC3AAPOBEC3GL3MBTL1RAB9A
Trifluoroacetic Acid SCHEMBL4883185 0.86 NAMPT (0.46) MAPTAPOBEC3AAPOBEC3GL3MBTL1RAB9A
Trifluoroacetic Acid SCHEMBL4877560 0.85 MAPK8 (0.39) MAPTAPOBEC3AAPOBEC3GL3MBTL1RAB9A
Trifluoroacetic Acid SCHEMBL4886219 0.85 NAMPT (0.39) MAPTAPOBEC3AAPOBEC3GL3MBTL1RAB9A
Trifluoroacetic Acid SCHEMBL4882365 0.84 L3MBTL1 (0.39) MAPTAPOBEC3AAPOBEC3GL3MBTL1RAB9A
Trifluoroacetic Acid SCHEMBL4884485 0.84 NAMPT (0.46) CA2MAPK8
SCHEMBL4622750 0.83 MEN1 (0.39) MAPTAPOBEC3AAPOBEC3GL3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269170-A1 Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors SANOFI-AVENTIS (FR) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269170-A1 Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors NFKBIA, IKBKB, IKBKE PLK1 154/4885TRPV1 3582/4885HSP90AA1 3212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.